Starzl T
Department of Surgery, Falk Clinic, Pittsburgh, PA 15213.
Bull Acad Natl Med. 1991 Jun-Jul;175(6):835-47; discussion 847-8.
The transplantation of multiple abdominal viscera including liver-duodenum-pancreas, liver-stomach-duodenum-pancreas, and liver-intestine is being performed with increasing frequency and success. These procedures and other variations are derived from a seldom used multivisceral operation in which all of the foregoing organs are transplanted in bloc. It is described here how the full multivisceral transplantation and its less extensive derivatives are based on the same principles of procurement, preservation, and postoperative management. With all of these multiple organ permutations and with intestinal transplantation alone, management is complicated by inclusion in the grafts of a large lymphoreticular component which is capable of causing graft versus host disease (GVHD). Because of a systematic error in therapeutic philosophy, past efforts have been directed at altering or damaging the lymphoreticular cells by pretreatment of the donor or of the organs with drugs, irradiation or other means. From recent observations, the alternative approach is suggested of keeping these lymphoid depots intact which then become the site of 2 way cell traffic after transplantation. Under powerful immunosuppression such as that provided with FK 506, the donor lymphoreticular cells can circulate in the recipient without causing clinical GVHD, and the lymphoreticular cells in the graft become those of the recipient (local chimerism) without causing rejection. Even with avoidance of rejection and GVHD, metabolic interrelations between the grafted organs, and also between the graft organs and retained recipient viscera can affect the fate of the individual transplanted organs or retained recipient organs. The best delineated of these metabolic influences are mediated by the endogenous splanchnic hepatotrophic factors of which insulin has been the most completely studied. An understanding of these various immunologic and non-immunologic factors combined with the more potent immunosuppression which is now available is sure to stimulate efforts at transplantation of abdominal organs and particularly of the hollow viscera which heretofore have resisted such clinical efforts.
包括肝 - 十二指肠 - 胰腺、肝 - 胃 - 十二指肠 - 胰腺以及肝 - 肠在内的多种腹部脏器移植的开展频率和成功率都在不断提高。这些手术方式及其他变体均源自一种很少使用的多脏器手术,即上述所有器官整块移植。本文介绍了全多脏器移植及其范围较小的衍生手术是如何基于相同的获取、保存及术后管理原则进行的。在所有这些多器官组合以及单独进行肠道移植时,由于移植物中包含大量能够引发移植物抗宿主病(GVHD)的淋巴网状成分,管理变得复杂。由于治疗理念上的系统性错误,过去的努力一直致力于通过药物、辐射或其他手段对供体或器官进行预处理,以改变或损伤淋巴网状细胞。基于最近的观察结果,建议采用另一种方法,即保持这些淋巴组织库完整,使其在移植后成为双向细胞运输的场所。在诸如FK 506提供的强大免疫抑制作用下,供体淋巴网状细胞可以在受体中循环而不引发临床GVHD,移植物中的淋巴网状细胞会变成受体的细胞(局部嵌合)而不引发排斥反应。即使避免了排斥反应和GVHD,移植器官之间以及移植器官与保留的受体脏器之间的代谢相互关系仍可能影响单个移植器官或保留的受体器官的命运。这些代谢影响中最明确的是由内源性内脏肝细胞营养因子介导的,其中胰岛素是研究最为全面的。对这些各种免疫和非免疫因素的理解,再加上现有的更强效免疫抑制方法,必将推动腹部器官移植的努力,特别是对迄今为止一直抗拒此类临床尝试的中空脏器的移植。